Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Vortioxetine for Cognitive Deficits in Persons with Post-COVID-19 Condition
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202112GSM
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$13,825Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
University of TorontoResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Post acute and long term health consequences
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified